Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6442a0ad5fc87e9dc08300f7bfbcc81d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6dd4da1b5d68f5fdbf9f5b65fa125e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13f220b39ad6cab07f901cd6144f293a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc5ff3d58d64f77f29aa7ad9e74a1882 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-533 |
filingDate |
2003-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3220d69c4d444ab1f19a86a2e1941d5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_908047e70c5d37caa88e2c9c236b2531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3303f8650b991b197b44783c84cb7bf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d15ec5d02f5572d59bee3cbf31eae61 |
publicationDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004016223-A2 |
titleOfInvention |
Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
abstract |
Provided herein is a novel and useful method for evaluating the ability of compounds or agents to decrease the activity of microsomal prostaglandin E synthase or hematopoietic prostaglandin D synthase to produce their respective prostaglandin products. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8440417-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006012259-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009286261-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9937175-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101178144-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8568967-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008121670-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011044307-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9469627-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006123677-A1 |
priorityDate |
2002-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |